International Conference on Immunometabolism and Neuroinflammation (ICIN - 26)

This session will explore the intricate immunometabolic pathways that contribute to the pathogenesis of various neurological disorders. Emphasis will be placed on understanding how metabolic dysregulation influences immune responses in the brain.

This track will focus on the cellular and molecular mechanisms underlying neuroinflammation and its role in neurological diseases. Discussions will include potential therapeutic strategies aimed at modulating neuroinflammatory responses.

This session will delve into the role of immune cell signaling in regulating brain metabolism and function. Presentations will highlight how immune cells interact with metabolic pathways to influence neuronal health.

This track will examine the relationship between metabolic health and neuroimmunological processes. Researchers will present findings on how metabolic disorders can impact immune function in the central nervous system.

This session will investigate the bidirectional relationship between inflammation and neurodegeneration. It will highlight recent research on how inflammatory processes can exacerbate neurodegenerative conditions.

This track will explore the complex interactions between the immune system and the nervous system in both health and disease contexts. Insights into how these interactions can be manipulated for therapeutic benefit will be discussed.

This session will focus on the role of various metabolic pathways in the regulation of immune responses. Researchers will present data on how metabolic changes can influence immune cell function and behavior.

This track will highlight the interdisciplinary nature of neuroimmunology, showcasing research that bridges neuroscience and immunology. Discussions will focus on collaborative approaches to understanding brain-immune interactions.

This session will explore the impact of gut microbiota on immunometabolic processes and neuroinflammatory responses. Presentations will address how microbiome modulation can influence brain health.

This track will focus on the identification and validation of emerging biomarkers related to immunometabolism and neuroinflammation. Researchers will discuss their potential for improving diagnosis and treatment of neurological disorders.

This session will showcase innovative therapeutic strategies targeting immunometabolic pathways to treat neurological disorders. Emphasis will be placed on novel drug development and clinical trial outcomes.